Cargando…
The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
Hepatocellular carcinoma (HCC) is the main liver malignancy and has a high mortality rate. The discovery of novel biomarkers for early diagnosis, prognosis, and stratification purposes has the potential to alleviate its disease burden. Mass spectrometry (MS) is one of the principal technologies used...
Autores principales: | Shen, Eric Yi-Liang, U, Mei Ran Abellona, Cox, I. Jane, Taylor-Robinson, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609223/ https://www.ncbi.nlm.nih.gov/pubmed/37887384 http://dx.doi.org/10.3390/metabo13101059 |
Ejemplares similares
-
The utility of biomarkers in hepatocellular carcinoma: review of urine-based (1)H-NMR studies – what the clinician needs to know
por: Cartlidge, Caroline R, et al.
Publicado: (2017) -
The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017) -
Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction
por: Dumenci, Ozbil E, et al.
Publicado: (2020) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007) -
Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Jang, Han Na, et al.
Publicado: (2021)